Clinical Impact of the Volumetric Quantification of Ventricular Secondary Mitral Regurgitation by Three-dimensional Echocardiography.

effective regurgitant orifice area heart failure hospitalization left ventricular function prognosis regurgitant volume secondary mitral regurgitation

Journal

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
ISSN: 1097-6795
Titre abrégé: J Am Soc Echocardiogr
Pays: United States
ID NLM: 8801388

Informations de publication

Date de publication:
18 Jan 2024
Historique:
received: 20 09 2023
revised: 08 01 2024
accepted: 09 01 2024
medline: 21 1 2024
pubmed: 21 1 2024
entrez: 20 1 2024
Statut: aheadofprint

Résumé

The assessment of ventricular secondary mitral regurgitation (v-SMR) severity through effective regurgitant orifice area (EROA) and regurgitant volume (RegVol) calculations using the proximal isovelocity surface area (PISA) method and the two-dimensional echocardiography volumetric method (2DEVM) is prone to underestimation. Accordingly, we sought to investigate the accuracy of the three-dimensional echocardiography volumetric method (3DEVM) and its association with outcomes in v-SMR patients. We included 229 patients (70 ± 13 years, 74% men) with v-SMR. We compared EROA and RegVol calculated by 3DEVM, 2DEVM, and PISA methods. The endpoint was a composite of heart failure hospitalization and death for any cause. After a mean follow-up of 20 ± 11 months, 98 patients (43%) reached the endpoint. RegVol and EROA calculated by 3DEVM were larger than those calculated by 2DEVM and PISA. Using ROC curve analysis, both EROA [Area Under the Curve (AUC) 0.75 (95% CI 0.68-0.81)] (p=0.008) and RegVol (AUC 0.75 (95% CI 0.68-0.82) (p=0.02) measured by 3DEVM showed the highest association with the outcome at 2 years compared to PISA and 2DEVM (p<0.05 for all). Kaplan-Meier analysis demonstrated a significantly higher rate of events in patients with EROA≥0.3 cm EROA and RegVol calculated by 3DEVM were independently associated with the endpoint, improving the risk stratification of patients with v-SMR compared to 2DEVM and PISA methods.

Sections du résumé

BACKGROUND BACKGROUND
The assessment of ventricular secondary mitral regurgitation (v-SMR) severity through effective regurgitant orifice area (EROA) and regurgitant volume (RegVol) calculations using the proximal isovelocity surface area (PISA) method and the two-dimensional echocardiography volumetric method (2DEVM) is prone to underestimation. Accordingly, we sought to investigate the accuracy of the three-dimensional echocardiography volumetric method (3DEVM) and its association with outcomes in v-SMR patients.
METHODS METHODS
We included 229 patients (70 ± 13 years, 74% men) with v-SMR. We compared EROA and RegVol calculated by 3DEVM, 2DEVM, and PISA methods. The endpoint was a composite of heart failure hospitalization and death for any cause.
RESULTS RESULTS
After a mean follow-up of 20 ± 11 months, 98 patients (43%) reached the endpoint. RegVol and EROA calculated by 3DEVM were larger than those calculated by 2DEVM and PISA. Using ROC curve analysis, both EROA [Area Under the Curve (AUC) 0.75 (95% CI 0.68-0.81)] (p=0.008) and RegVol (AUC 0.75 (95% CI 0.68-0.82) (p=0.02) measured by 3DEVM showed the highest association with the outcome at 2 years compared to PISA and 2DEVM (p<0.05 for all). Kaplan-Meier analysis demonstrated a significantly higher rate of events in patients with EROA≥0.3 cm
CONCLUSIONS CONCLUSIONS
EROA and RegVol calculated by 3DEVM were independently associated with the endpoint, improving the risk stratification of patients with v-SMR compared to 2DEVM and PISA methods.

Identifiants

pubmed: 38244817
pii: S0894-7317(24)00007-5
doi: 10.1016/j.echo.2024.01.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Michele Tomaselli (M)

Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan, Italy.

Luigi P Badano (LP)

Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan, Italy; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy. Electronic address: luigi.badano@unimib.it.

Giorgio Oliverio (G)

Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan, Italy.

Emanuele Curti (E)

Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Cinzia Pece (C)

Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Paolo Springhetti (P)

Department of Medicine, Division of Cardiology, University of Verona, Verona, Italy.

Salvatore Milazzo (S)

Division of Cardiology, University Hospital Paolo Giaccone, Palermo, Italy.

Alexandra Clement (A)

Internal Medicine Department, "Grigore T. Popa", University of Medicine and Pharmacy, Iasi, Romania.

Marco Penso (M)

Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan, Italy.

Mara Gavazzoni (M)

Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan, Italy.

Diana R Hădăreanu (DR)

Department of Cardiology, Clinical Emergency County Hospital of Craiova, Craiova, Romania.

Sorina Baldea Mihaila (SB)

Cardiology Department, Carol Davila, University of Medicine and Pharmacy, Bucharest, Romania.

Giordano M Pugliesi (GM)

Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan, Italy; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Caterina Delcea (C)

Cardiology Department, Carol Davila, University of Medicine and Pharmacy, Bucharest, Romania.

Denisa Muraru (D)

Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan, Italy; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Classifications MeSH